Delivery Order SPE2DB20D3101-SPE2DB23FRFA3

Award Date 3/13/23
Potential Completion Date 3/14/23
Potential Value $39K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a $7,672.44 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Xarelto 10 mg tablets. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Xarelto 20 mg tablets. The $38,265.62 award was made on February 2, 2023, with a completion date of February 3, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued up to $999,999,999.00 and running through November 2026. The IDC serves...
The Defense Logistics Agency (DLA) awarded a $14,120.69 delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,562,242,465 units of the pharmaceutical product Xarelto 20 mg tablets. The contract has a completion date of September 21, 2023 and is a firm-fixed-price agreement. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical,...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 15 mg Xarelto tablets for a total ceiling value of $1,236.54. This order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. (doing business as Amerisourcebergen), valued at up to $999,999,999.00 through November 2026. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
The Defense Logistics Agency (DLA) awarded a $1,976.35 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Xarelto 20 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00, which runs through December 2025. The IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $4,671.33 to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract provides for the delivery of Xarelto 20 mg tablets to support military treatment programs and facilities. This delivery order was issued under an indefinite delivery contract (IDC) with a potential ceiling value of $999,999,999.00, which serves as the primary vehicle for AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Xarelto 20 mg tablets. The contract, valued at $27,220.56, is a delivery order with a firm fixed price and an ultimate completion date of October 17, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00 and running through...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,103.51 firm fixed-price delivery order is for the supply of Xarelto 15 mg tablets. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical...
This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $11,765.12 firm fixed-price delivery order is for the supply of Xarelto 20 mg tablets, a medication used to treat cardiovascular health conditions. The contract has an ultimate completion date of February 29, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
The federal government awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of XARELTO 20 MG tablets. The $12,360.72 firm-fixed price contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of December 20, 2023. This contract award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued up to $999,999,999.00 and running through November...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRFA3
    Delivery Order

The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Xarelto 15 mg tablets. The $39,072.11 firm-fixed-price contract has a period of performance through March 14, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract was awarded through full and open competition with no set-aside designation.

Generated 2/27/25, 11:47 AM